Angiogenesis-targeting secretome therapies may provide a new therapy for ischemic heart disease. Here, the authors show that CCL28 promotes angiogenesis via CCR10 signaling, and recombinant CCL28 offers therapeutic potential in ischemic models, including diabetic conditions.
- Kun Yang
- Hanchuan Chen
- Kaiyang Lin
